Narjes Saheb Sharif‐Askari

18.8k total citations
81 papers, 1.1k citations indexed

About

Narjes Saheb Sharif‐Askari is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Narjes Saheb Sharif‐Askari has authored 81 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 22 papers in Molecular Biology and 19 papers in Immunology. Recurrent topics in Narjes Saheb Sharif‐Askari's work include COVID-19 Clinical Research Studies (24 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Long-Term Effects of COVID-19 (12 papers). Narjes Saheb Sharif‐Askari is often cited by papers focused on COVID-19 Clinical Research Studies (24 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Long-Term Effects of COVID-19 (12 papers). Narjes Saheb Sharif‐Askari collaborates with scholars based in United Arab Emirates, Saudi Arabia and Canada. Narjes Saheb Sharif‐Askari's co-authors include Fatemeh Saheb Sharif‐Askari, Rabih Halwani, Qutayba Hamid, Saba Al Heialy, Mohamad‐Hani Temsah, Rifat Hamoudi, Syed Azhar Syed Sulaiman, Habiba Alsafar, Swati Goel and Salah Abusnana and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Narjes Saheb Sharif‐Askari

77 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Narjes Saheb Sharif‐Askari United Arab Emirates	17	507	260	186	179	115	81	1.1k
Jae Won Yang South Korea	16	288 0.6×	217 0.8×	136 0.7×	108 0.6×	138 1.2×	75	1.2k
Xianghong Yang China	17	356 0.7×	188 0.7×	158 0.8×	80 0.4×	144 1.3×	44	931
Yan Qin China	13	819 1.6×	279 1.1×	436 2.3×	174 1.0×	165 1.4×	59	1.7k
Joyce Zhou United States	18	518 1.0×	325 1.3×	220 1.2×	72 0.4×	170 1.5×	37	1.5k
Tielong Chen China	13	613 1.2×	149 0.6×	339 1.8×	94 0.5×	140 1.2×	43	1.1k
Qiongjing Yuan China	22	253 0.5×	411 1.6×	115 0.6×	94 0.5×	137 1.2×	57	1.4k
Jianlei Cao China	13	345 0.7×	205 0.8×	232 1.2×	52 0.3×	116 1.0×	31	816
Xiangning Yuan China	14	246 0.5×	217 0.8×	112 0.6×	62 0.3×	95 0.8×	26	895
Xiangcheng Xiao China	20	274 0.5×	405 1.6×	129 0.7×	127 0.7×	147 1.3×	71	1.4k
Yi‐Chang Cheng Taiwan	12	898 1.8×	208 0.8×	276 1.5×	63 0.4×	96 0.8×	18	1.4k

Countries citing papers authored by Narjes Saheb Sharif‐Askari

Since Specialization

Citations

This map shows the geographic impact of Narjes Saheb Sharif‐Askari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narjes Saheb Sharif‐Askari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narjes Saheb Sharif‐Askari more than expected).

Fields of papers citing papers by Narjes Saheb Sharif‐Askari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narjes Saheb Sharif‐Askari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narjes Saheb Sharif‐Askari. The network helps show where Narjes Saheb Sharif‐Askari may publish in the future.

Co-authorship network of co-authors of Narjes Saheb Sharif‐Askari

This figure shows the co-authorship network connecting the top 25 collaborators of Narjes Saheb Sharif‐Askari. A scholar is included among the top collaborators of Narjes Saheb Sharif‐Askari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narjes Saheb Sharif‐Askari. Narjes Saheb Sharif‐Askari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khalil, Bariaa, Narjes Saheb Sharif‐Askari, Balachandar Selvakumar, et al.. (2025). Vitamin D3 suppresses NLRP3 inflammasome pathway and enhances steroid sensitivity in a neutrophilic steroid hyporesponsive asthma mouse model. Inflammation Research. 74(1). 51–51. 1 indexed citations

Sharif‐Askari, Fatemeh Saheb, et al.. (2025). The potential role of nanobodies in asthma therapy. Frontiers in Pharmacology. 15. 1510806–1510806.

Sharif‐Askari, Fatemeh Saheb, et al.. (2025). Intranasal dupilumab improves responsiveness to steroid in an asthma mouse model. Inflammation Research. 74(1). 43–43. 1 indexed citations

Sharif‐Askari, Narjes Saheb, et al.. (2024). Elizabethkingia meningoseptica in Dubai, United Arab Emirates: A 7-year multicenter study. American Journal of Infection Control. 53(3). 326–329.

Sharif‐Askari, Narjes Saheb, Shirin Hafezi, Fatemeh Saheb Sharif‐Askari, et al.. (2024). Multiple inborn errors of type I IFN immunity in a 33-year-old male with a fatal case of COVID-19. Heliyon. 10(8). e29338–e29338. 1 indexed citations

Sharif‐Askari, Narjes Saheb, Roberta Cagliani, Rakhee K. Ramakrishnan, et al.. (2024). Inhibiting DNA Sensing Pathway Controls Steroid Hyporesponsive Lung Inflammation. Advanced Biology. 9(1). e2400230–e2400230. 2 indexed citations

Sharif‐Askari, Narjes Saheb, et al.. (2023). Investigating the Association between Diabetic Neuropathy and Vitamin D in Emirati Patients with Type 2 Diabetes Mellitus. Cells. 12(1). 198–198. 5 indexed citations

Mogas, Andrea, Mahmood Yaseen Hachim, Abiola Senok, et al.. (2023). Cell free ACE2 RNA: A potential biomarker of COVID-19 severity. Respiratory Medicine. 219. 107409–107409. 1 indexed citations

Ahmed, Samrein B. M., et al.. (2023). Assessing the Link between Diabetic Metabolic Dysregulation and Breast Cancer Progression. International Journal of Molecular Sciences. 24(14). 11816–11816. 3 indexed citations

10.

Salameh, Laila, Narjes Saheb Sharif‐Askari, M. Al-Sharhan, et al.. (2022). In Silico Bioinformatics Followed by Molecular Validation Using Archival FFPE Tissue Biopsies Identifies a Panel of Transcripts Associated with Severe Asthma and Lung Cancer. Cancers. 14(7). 1663–1663. 3 indexed citations

11.

Mahmoud, Sally, Subhashini Ganesan, Narjes Saheb Sharif‐Askari, et al.. (2022). Durability of antibodies post vaccination with two doses of inactivated BBIBP-CorV vaccine. Current Medical Research and Opinion. 38(12). 2069–2075. 1 indexed citations

12.

Sharif‐Askari, Fatemeh Saheb, Imad M. Tleyjeh, Narjes Saheb Sharif‐Askari, et al.. (2022). Sotrovimab Lowers the Risk of COVID‐19 Related Hospitalization or Death in a Large Population Cohort in the United Arab Emirates. Clinical Pharmacology & Therapeutics. 112(6). 1214–1223. 6 indexed citations

13.

Bouzid, Amal, Mahmood Yaseen Hachim, Narjes Saheb Sharif‐Askari, et al.. (2022). ACE2 polymorphisms impact COVID-19 severity in obese patients. Scientific Reports. 12(1). 21491–21491. 10 indexed citations

14.

Sharif‐Askari, Fatemeh Saheb, et al.. (2021). Early administration of remdesivir to COVID-19 patients associates with higher recovery rate and lower need for ICU admission: A retrospective cohort study. PLoS ONE. 16(10). e0258643–e0258643. 21 indexed citations

15.

Bajbouj, Khuloud, Rakhee K. Ramakrishnan, Maha Saber-Ayad, et al.. (2021). PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells. International Journal of Molecular Sciences. 22(11). 6131–6131. 19 indexed citations

16.

Sharif‐Askari, Fatemeh Saheb, Narjes Saheb Sharif‐Askari, Rabih Halwani, et al.. (2020). Low Vitamin D Serum Level Is Associated with HDL-C Dyslipidemia and Increased Serum Thrombomodulin Levels of Insulin-Resistant Individuals. Diabetes Metabolic Syndrome and Obesity. Volume 13. 1599–1607. 19 indexed citations

17.

Sharif‐Askari, Fatemeh Saheb, et al.. (2020). Blood Neutrophil-to-Lymphocyte Ratio and Urine IL-8 Levels Predict the Type of Bacterial Urinary Tract Infection in Type 2 Diabetes Mellitus Patients. Infection and Drug Resistance. Volume 13. 1961–1970. 12 indexed citations

18.

Bendardaf, Riyad, et al.. (2020). Incidence and Clinicopathological Features of Breast Cancer in the Northern Emirates: Experience from Sharjah Breast Care Center. International Journal of Women s Health. Volume 12. 893–899. 5 indexed citations

19.

Sharif‐Askari, Fatemeh Saheb, Narjes Saheb Sharif‐Askari, Mohammadreza Javadi, & Kheirollah Gholami. (2017). Adverse drug reactions reported to the drug and poison information center of Tehran, Iran. PLoS ONE. 12(9). e0185450–e0185450. 8 indexed citations

20.

Sharif‐Askari, Narjes Saheb, et al.. (2014). Hospitalized Heart Failure Patients with Preserved vs. Reduced Ejection Fraction in Dubai, United Arab Emirates: A Prospective Study. European Journal of Heart Failure. 16(4). 454–460. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact